We herein studied how ISWI ATPase SMARCA5/SNF2H controls in AML the proliferation and gene expression of myeloblasts as SMARCA5 appeared to be an interesting target for anti-AML therapy. The gene discussed is SMARCA5; the disease is acute myeloid leukemia.